{"id":"paraoxon","rwe":[],"tags":[{"label":"paraoxon","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Cholinesterase","category":"target"},{"label":"BCHE","category":"gene"},{"label":"ACHE","category":"gene"},{"label":"CA2","category":"gene"},{"label":"S01EB10","category":"atc"},{"label":"Active","category":"status"},{"label":"Cholinergic Agents","category":"pharmacology"},{"label":"Cholinesterase Inhibitors","category":"pharmacology"},{"label":"Enzyme Inhibitors","category":"pharmacology"},{"label":"Insecticides","category":"pharmacology"},{"label":"Neurotransmitter Agents","category":"pharmacology"},{"label":"Pesticides","category":"pharmacology"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"mintacol","offLabel":[],"synonyms":["paraoxon","oxyparathion","ethyl paraoxon","paraoxan","phosphachole","phosphacol","mintacol"],"timeline":[],"approvals":[],"brandName":"Mintacol","ecosystem":[],"mechanism":{"target":"Acetylcholinesterase, Carbonic anhydrase 1, Carbonic anhydrase 2","targets":[{"gene":"BCHE","source":"DrugCentral","target":"Cholinesterase","protein":"Cholinesterase"},{"gene":"ACHE","source":"DrugCentral","target":"Acetylcholinesterase","protein":"Acetylcholinesterase"},{"gene":"CA2","source":"DrugCentral","target":"Carbonic anhydrase 2","protein":"Carbonic anhydrase 2"},{"gene":"CA1","source":"DrugCentral","target":"Carbonic anhydrase 1","protein":"Carbonic anhydrase 1"}],"modality":"Small Molecule","drugClass":"paraoxon","explanation":"Think of acetylcholine like a key that unlocks certain functions in the body. When cholinesterase breaks it down, the key is removed, and those functions are turned off. By stopping cholinesterase from breaking down acetylcholine, Mintacol keeps the key in place, allowing those functions to stay active.","oneSentence":"Mintacol works by inhibiting the enzyme cholinesterase, which breaks down the neurotransmitter acetylcholine.","technicalDetail":"Mintacol exerts its effects by competitively inhibiting acetylcholinesterase, the enzyme responsible for hydrolyzing acetylcholine into choline and acetic acid, thereby increasing acetylcholine concentrations in the synaptic cleft."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4683","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=paraoxon","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=paraoxon","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:15:22.207550","biosimilars":[],"competitors":[{"drugName":"pilocarpine","drugSlug":"pilocarpine","fdaApproval":"1974-07-29","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"carbachol","drugSlug":"carbachol","fdaApproval":"1972-09-28","genericCount":2,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"echothiophate","drugSlug":"echothiophate","fdaApproval":"1960-06-27","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"demecarium","drugSlug":"demecarium","fdaApproval":"1959-08-05","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"neostigmine","drugSlug":"neostigmine","fdaApproval":"2013-05-31","genericCount":16,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"fluostigmine","drugSlug":"fluostigmine","fdaApproval":"1957-04-02","relationship":"same-class"},{"drugName":"acetylcholine","drugSlug":"acetylcholine","fdaApproval":"1973-10-09","patentStatus":"Unknown","relationship":"same-class"}],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"paraoxon","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"pilocarpine","brandName":"pilocarpine","genericName":"pilocarpine","approvalYear":"1974","relationship":"same-class"},{"drugId":"carbachol","brandName":"carbachol","genericName":"carbachol","approvalYear":"1972","relationship":"same-class"},{"drugId":"echothiophate","brandName":"echothiophate","genericName":"echothiophate","approvalYear":"1960","relationship":"same-class"},{"drugId":"demecarium","brandName":"demecarium","genericName":"demecarium","approvalYear":"1959","relationship":"same-class"},{"drugId":"neostigmine","brandName":"neostigmine","genericName":"neostigmine","approvalYear":"2013","relationship":"same-class"},{"drugId":"fluostigmine","brandName":"fluostigmine","genericName":"fluostigmine","approvalYear":"1957","relationship":"same-class"},{"drugId":"acetylcholine","brandName":"acetylcholine","genericName":"acetylcholine","approvalYear":"1973","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT02659735","phase":"PHASE1","title":"A Study to Assess the Relative Oral Bioavailability of JNJ-63623872 Administered as Oral Concept Formulations Compared to the Current Tablet Formulation","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-12","conditions":["Influenza A Virus"],"enrollment":90,"completionDate":"2016-04"},{"nctId":"NCT02690064","phase":"NA","title":"Mechanisms for Vascular Dysfunction and Exercise Tolerance in CF","status":"ACTIVE_NOT_RECRUITING","sponsor":"Augusta University","startDate":"2015-04","conditions":["Cystic Fibrosis"],"enrollment":13,"completionDate":"2027-01"},{"nctId":"NCT02115724","phase":"NA","title":"Nitric Oxide Bioavailability and Early Life Stress (NO-Stress)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Augusta University","startDate":"2014-04","conditions":["Cardiovascular Disease"],"enrollment":74,"completionDate":"2027-01"},{"nctId":"NCT04078048","phase":"NA","title":"Role of Antioxidants (Vitamin C and E) in the Management of Schizophrenia","status":"COMPLETED","sponsor":"University of Health Sciences Lahore","startDate":"2017-04-27","conditions":["Schizophrenia"],"enrollment":105,"completionDate":"2017-11-15"},{"nctId":"NCT01772758","phase":"PHASE2","title":"Cystic Fibrosis and Endothelial Function: At Rest and During Exercise","status":"COMPLETED","sponsor":"Augusta University","startDate":"2011-08","conditions":["Cystic Fibrosis"],"enrollment":64,"completionDate":"2016-06-21"},{"nctId":"NCT01846325","phase":"PHASE2,PHASE3","title":"The Effects of Administration of Combined Docosahexaenoic Acid and Vitamin E Supplements on Spermatogram and Seminal Plasma Oxidative Stress in Infertile Men With Asthenozoospermia","status":"COMPLETED","sponsor":"National Nutrition and Food Technology Institute","startDate":"2013-12","conditions":["Asthenozoospermia"],"enrollment":180,"completionDate":"2015-05"},{"nctId":"NCT00000479","phase":"PHASE3","title":"Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"1992-09","conditions":["Cardiovascular Diseases","Cerebrovascular Disorders","Coronary Disease","Heart Diseases","Myocardial Infarction","Myocardial Ischemia","Vascular Diseases"],"enrollment":39876,"completionDate":"2005-02"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"UNII":"Q9CX8P80JW","CHEBI":"CHEBI:27827","UMLSCUI":"C0030480","ChEMBL_ID":"CHEMBL23838","KEGG_DRUG":"D10529","DRUGBANK_ID":"DB13495","PUBCHEM_CID":"9395","MESH_DESCRIPTOR_UI":"D010261","MESH_SUPPLEMENTAL_RECORD_UI":"C121104"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":2464,"therapeuticAreas":["Neuroscience"],"atcClassification":{"source":"DrugCentral","atcCode":"S01EB10","allCodes":["S01EB10"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Mintacol is a small molecule that acts as a cholinesterase inhibitor. It is used as an ophthalmological drug against glaucoma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}